Zobrazeno 1 - 10
of 5 355
pro vyhledávání: '"Post COVID"'
Publikováno v:
Инфекция и иммунитет, Vol 14, Iss 4, Pp 747-755 (2024)
The issue of the state of specific and nonspecific resistance in the post-COVID period and the possible consequences of COVID-19 remains poorly understood. A clinical and laboratory examination of 124 patients was conducted at various time points aft
Externí odkaz:
https://doaj.org/article/6bc418d592fc49ca839ced123219183e
Autor:
King, Victor T., Chin, Wei Lee
Publikováno v:
Southeast Asia: A Multidisciplinary Journal, 2024, Vol. 24, Issue 2, pp. 150-163.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/SEAMJ-03-2024-0031
Autor:
Aya Mohamed Khaled Sakr, Tarek Ahmed Okasha, Marwa Abd El-Meguid Hamed, Maha Mohamed Sayed, Mariam Yehia Mohamed
Publikováno v:
Middle East Current Psychiatry, Vol 31, Iss 1, Pp 1-13 (2024)
Abstract Background COVID-19 infection is known to trigger a significant inflammatory response in the body. This response, characterized by elevated levels of cytokines including TNF-α that has proven to play a pivotal role in the severity and long-
Externí odkaz:
https://doaj.org/article/7f4643f89a004d21b4c306dbcfe7058e
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract This study explores the health-related quality of life (HRQoL) experienced by patients with Long COVD-19 using data from British Columbia’s post-COVID-19 Recovery Clinics. A retrospective cohort of 3463 patients was analyzed to assess HRQo
Externí odkaz:
https://doaj.org/article/a9306436f52e41778a2a2a280e36bb5f
Autor:
Leуla Sh. Dudchenko, Vladimir A. Beloglazov, Igor А. Yatskov, Galina N. Andreeva, Elena A. Solovyova, Irina V. Shulyak
Publikováno v:
Вестник восстановительной медицины, Vol 23, Iss 5, Pp 41-51 (2024)
Introduction. The multivariability of the clinical course of post-covid syndrome (PCS) is associated with genetic heterogeneity of the population, which leads to a high interest in the study of genotypes. Aim. To evaluate the role of Toll-like rec
Externí odkaz:
https://doaj.org/article/8559dc885bba4b4a86da0f39fa269a43
Autor:
Ermanno Cordelli, Paolo Soda, Sara Citter, Elia Schiavon, Christian Salvatore, Deborah Fazzini, Greta Clementi, Michaela Cellina, Andrea Cozzi, Chandra Bortolotto, Lorenzo Preda, Luisa Francini, Matteo Tortora, Isabella Castiglioni, Sergio Papa, Diego Sona, Marco Alì
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Long COVID is a multi-systemic disease characterized by the persistence or occurrence of many symptoms that in many cases affect the pulmonary system. These, in turn, may deteriorate the patient’s quality of life making it easier to develo
Externí odkaz:
https://doaj.org/article/c54e384d5fe54c018bf82f03f3251613
Autor:
Ahmed Burooj, Ruqia Al-Ali
Publikováno v:
Clinical and Research Journal in Internal Medicine, Vol 5, Iss 2, Pp 168-177 (2024)
The COVID-19 pandemic has posed significant challenges to global healthcare systems, leaving behind a myriad of unanswered questions and long-term consequences. One such consequence is the emergence of a clinical phenomenon known as Long COVID, chara
Externí odkaz:
https://doaj.org/article/09201729d6ef4cacb84622bbaf8c79c5
Publikováno v:
Сахарный диабет, Vol 27, Iss 5, Pp 441-450 (2024)
BACKGROUND: Since the emergence of coronavirus infection in clinical practice, particular attention has been paid to its acute phase. However, to date, the direct and indirect impact on patients with type 2 diabetes mellitus after recovery from coron
Externí odkaz:
https://doaj.org/article/957c0ac5c6134ab3846932813f14a0ef
Autor:
Marco Floridia, Marina Giuliano, Liliana Elena Weimer, Maria Rosa Ciardi, Piergiuseppe Agostoni, Paolo Palange, Patrizia Rovere Querini, Silvia Zucco, Matteo Tosato, Aldo Lo Forte, Paolo Bonfanti, Donato Lacedonia, Emanuela Barisione, Stefano Figliozzi, Paola Andreozzi, Cecilia Damiano, Flavia Pricci, Graziano Onder, the I. S. S. Long-COVID Study Group
Publikováno v:
BMC Medicine, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background Long-COVID symptoms remain incompletely defined due to a large heterogeneity in the populations studied, case definitions, and settings of care. The aim of this study was to assess, in patients accessing care for Long-COVID, the p
Externí odkaz:
https://doaj.org/article/27a513781e7b40259d6402f4e44219a0
Autor:
Warren Szewczyk, Annette L. Fitzpatrick, Herve Fossou, Nicole L. Gentile, Nona Sotoodehnia, Surabhi B. Vora, T. Eoin West, Jeanne Bertolli, Jennifer R. Cope, Jin-Mann S. Lin, Elizabeth R. Unger, Quan M. Vu
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Recovery from SARS CoV-2 infection is expected within 3 months. Long COVID occurs after SARS-CoV-2 when symptoms are present for more than 3 months that are continuous, relapsing and remitting, or progressive. Better understanding
Externí odkaz:
https://doaj.org/article/e2410f2f32fb467a8917026d2e78a65c